MCX , 5% upside Call & Research Report by Institutional Research Desk at HDFC Securities Analyst:Mr. Amit Chandra Report Date: 23 January 2021 CMP Rs. 1675 Target price Rs. 1770 Multi Commodity Exchange (Q3FY21 Results Review) Taking a pause; recovery awaited. Maintain ADD MCX delivered a weak revenue (-15.7% QoQ) and margin performance but was […]
Read more..Symphony, 12% upside Call & Research Report by Institutional Research Desk at HDFC Securities Analysist:Mr. Naveen Trivedi Report Date: 23 January 2021 CMP Rs. 990 Target price Rs. 1115 Symphony (Q3FY21 Results Review) Domestic in line; RoW improving. Maintain ADD Symphony’s domestic revenue was in line (33% down YoY), while exports were down by 79% […]
Read more..TCS ltd, 10% upside Call & Research Report by HDFC Securities Institutional Research Report Date: 11 January 2021 CMP Rs. 3120 Target price Rs. 3435 Stellar performance continues We maintain ADD on TCS, following a back-to-back stellar performance and positive commentary. Key positives included (1) broad-based (verticals & services) growth outperformance (strongest 3Q in nine […]
Read more..Research Report by Institutional Research Desk at HDFC SecuritiesResearch Analysts: Mr. Varun Lohchab, Head & Mr. Naveen TrivediReport Date: 19 November 2020 Jubilant FoodWorks (Q2FY21 Results Review) Recovery continues; priced-in. Maintain REDUCECMP (as on 12 Nov 2020) Rs 2,339Target Price Rs 1,800 Jubilant reported mixed 2Q with a marginal miss in revenue and beat in the margin. […]
Read more..Research Report by Institutional Research Desk at HDFC SecuritiesResearch Analysts:Mr.Nilesh Ghuge & Mr. Harshad KatkarReport Date: 21 November 2020 Sudarshan Chemical , Initiating Coverage Leaping into the league of giantsCMP (as on 19 Nov 2020) INR 453Target Price INR 550 For the period over August-16 to November-20, the stock of Sudarshan Chemical Industries Ltd (SCIL) […]
Read more..Research Report by Institutional Research Desk at HDFC Securities Research Analysts : Mr. Varun Lohchab,Head & Mr. Naveen Trivedi Report Date: 4 November 2020 Dabur (Q2FY21 Results Review) | Capitalising rural and healthcare portfolio. Maintain REDUCE Dabur’s 2QFY21 saw strong revenue growth, beating our as well as the street’s expectations. Domestic val/vol growth was at 20/17% […]
Read more..Research Report by Institutional Research Desk at HDFC Securities Research Analyst : Ms. Bansi Desai Report Date: 4 November 2020 Sun Pharma (Q2FY21 Results Review) Specialty recovery is encouraging. Maintain ADD CMP (as on 03 Nov 2020) Rs 485 Target Price Rs 565 Recovery in specialty business (USD 108mn, +38% QoQ) along with improved gross margin […]
Read more..Research Report by Institutional Research Desk at HDFC Securities Research Analyst : Mr.Rajesh Ravi Report Date : 2 November 2020 Orient Cem...
You must subscribe to our premium plans to view this content. CLICK HERE to Subscribe ! Read more..Research Report by Institutional Research Desk at HDFC Securities Research Analyst : Mr.Darpin Shah Report Date : 2 November 2020 Indusind B...
You must subscribe to our premium plans to view this content. CLICK HERE to Subscribe ! Read more..Research Report by Institutional Research Desk at HDFC Securities Research Analyst : Mr.Darpin Shah Report Date : 3 November 2020 ICICI Bank...
You must subscribe to our premium plans to view this content. CLICK HERE to Subscribe ! Read more..